Table 3

Characteristics of the SDPP subjects receiving a diagnosis of NGT at baseline

Follow-up diagnosisWithout T2DPrediabetesWith T2DP value (ANOVA)
N*370314158
Male (%)200 (54)179 (57)110 (69)0.0019
Baseline
Age (years)47.3 (4.7)48.2 (4.4)48.2 (4.6)0.0102
Height (m)1.73 (0.09)1.72 (0.09)1.74 (0.09)0.1294
Weight (kg)74.9 (12.4)81.8 (14.1)85.6 (15.2)<0.0001
BMI (kg/m2)24.9 (3.2)27.6 (4.1)28.4 (4.7)<0.0001
WHR0.84 (0.07)0.87 (0.07)0.90 (0.06)<0.0001
SBP121 (14)128 (15)130 (15)<0.0001
DBP76 (9)80 (9)81 (9)<0.0001
Fasting glucose (mmol/L)4.6 0 (0.49)4.94 (0.50)5.06 (0.56)<0.0001
Fasting insulin (mU/L)14.2 (6.3)17.5 (9.0)21.2 (10.2)<0.0001
sCD93 (ng/mL)166 (44)161 (44)158 (45)0.0700
Current smokers (%)89 (22.2)105 (29.2)63 (36.8)0.0012
BP treatment (%)19 (4.8)38 (10.6)18 (10.6)0.0055
Follow-up
Follow-up time9.1 (1.3)9.2 (1.2)9.5 (1.2)0.0025
Age (years)56.5 (4.8)57.4 (4.5)57.7 (4.7)0.0021
Height (m)1.72 (0.09)1.71 (0.09)1.73 (0.09)0.0727
Weight (kg)77.1 (13.3)86.5 (15.9)91.0 (18.2)<0.0001
BMI (kg/m2)25.9 (3.4)29.4 (4.8)30.3 (5.8)<0.0001
WHR0.88 (0.06)0.91 (0.06)0.94 (0.07)<0.0001
SBP133 (17)143 (17)144 (18)<0.0001
DBP82 (10)87 (10)87 (11)<0.0001
Fasting glucose (mmol/L)4.86 (0.46)5.72 (0.68)7.35 (2.18)<0.0001
Fasting insulin (mU/L)14.6 (6.0)21.2 (11.9)26.6 (13.2)<0.0001
sCD93 (ng/mL)153 (42)154 (51)154 (48)0.9654
ΔsCD9313 (46)7 (52)4 (55)0.0814
Current smokers (%)61 (15.3)73 (20.3)34 (20.0)0.1486
T2D treatment (%)0039 (22.8)<0.0001
BP treatment (%)64 (16.0)133 (36.9)72 (42.1)<0.0001
  • Values are presented as the mean (SD) for continuous measures and n (%) for categorical measures, unless otherwise indicated. Prediabetes was defined as impaired glucose tolerance and/or impaired fasting glucose. ΔsCD93, baseline sCD93 − follow-up sCD93. Boldface type indicates nominal statistical significance. BP, blood pressure.

  • *Smallest n for any variable.